InformationTA-02 TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM. TA-02 especially inhibits TGFBR-2 .TargetsTGFβRII : p38 MAPK (Cell-free assay) : 20 nM.
InformationTA-02 TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM. TA-02 especially inhibits TGFBR-2 .TargetsTGFβRII : p38 MAPK (Cell-free assay) : 20 nM.
InformationTA-02 TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM. TA-02 especially inhibits TGFBR-2 .TargetsTGFβRII : p38 MAPK (Cell-free assay) : 20 nM.
InformationTA-02 TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM. TA-02 especially inhibits TGFBR-2 .TargetsTGFβRII : p38 MAPK (Cell-free assay) : 20 nM.
InformationTazemetostat (EPZ-6438) Tazemetostat (EPZ-6438, E7438) is a potent, and selective EZH2 inhibitor with K i and IC50 of 2.5 nM and 11 nM in cell-free assays, exhibiting a 35-fold selectivity versus EZH1 and >:4,500-fold selectivity
InformationTazemetostat (EPZ-6438) Tazemetostat (EPZ-6438, E7438) is a potent, and selective EZH2 inhibitor with K i and IC50 of 2.5 nM and 11 nM in cell-free assays, exhibiting a 35-fold selectivity versus EZH1 and >:4,500-fold selectivity